Search Results 841-850 of 19270 for hemoglobin

1. Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer - Mayo Clinic

   Hemoglobin ≥ 10 g/dL; Creatinine ≤ 1.5 times the upper limit of normal with creatinine clearance ≥ 50 mL/min using the Modified Cockcroft-Gault method ...

2. A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer - Mayo Clinic

   hemoglobin ≥9 g/dL;; serum bilirubin ≤1.5 × upper limit of normal (ULN) or ≤ × ULN for patients with Gilbert's disease;; CrCl ≥30 mL/min as measured by 24 ...

3. Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL;; Total bilirubin ≤ 1.5 X upper limit of normal (ULN); if total bilirubin > 1.5 X ULN then direct bilirubin ≤ ULN;; Aspartate ...

4. Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer - Mayo Clinic

   Hemoglobin ≥ 9 g/dL; subjects with hemoglobin ≥ 8-9 g/dL may be included with approval from the Medical Monitor;; In subjects transfused before study entry ...

5. Metabolic syndrome - Symptoms & causes - Mayo Clinic

   Having three or more specific risk factors, such as high blood pressure or abdominal fat, boosts your risk of type 2 diabetes and heart disease.

6. Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With wAIHA or CAD - Mayo Clinic

   Hemoglobin <11 g/dL. Signs of hemolysis with abnormal values by any of the following hemolytic markers: Increased absolute reticulocyte counts (above ULN); ...

7. A Study Of Ex Vivo Expansion (ACT-X) - Mayo Clinic

   The following laboratory values obtained ≤ 28 days prior to registration. Hemoglobin ≥910.0 g/dl. Absolute neutrophil count (ANC) ≥1500/mm3. Platelet count ...

8. A Study to Evaluate Belinostat and Guadecitabine or ASTX727 to Treat Unresectable and Metastatic Conventional Chondrosarcoma - Mayo Clinic

   Hemoglobin 8 g/dL;; Platelet count ≥ 75,000/mm^3;; Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN);; Aspartate aminotransferase (AST) ...

9. Investigational Trial To Evaluate XC001 Delivered Via An Cardiac Catheter In Subjects With Chronic Angina. - Mayo Clinic

   Body mass index \> 45 kg/m2. 5. Hemoglobin \< 10 g/dL, absolute neutrophil count \< 1.2 × 103 per µL, platelet count \< 75,000 per µL, alanine ...

10. A Study of the Effectiveness of Sulfasalazine in Preventing Acute Diarrhea in Patients with Cancer who are Undergoing Pelvic Radiation Therapy - Mayo Clinic

    Life expectancy ≥ 6 months; Hemoglobin ≥ 10.0 g/dL; Leukocytes ≥ 3,500/mm^3; ANC ≥ 1,500/mm^3; Platelet count ≥ 100,000/mm^3; Creatinine ≤ 1.5 times upper ...